A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...
A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...
Zacks Investment Research on MSN2d
FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib (Revised)Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor ...
Researchers from the University of South Australia have found a way to make cannabidiol (CBD) work better in the body, ...
During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...
including an RT editing program for a rare liver disease and a program targeting amyotrophic lateral sclerosis (ALS). “This financing is a testament to the hard work of our team as well as our ...
Topas Therapeutics today announced the publication of data highlighting the ability of its proprietary antigen-coupled ...
A recent research which used NHANES data from 2015 to 2018 discovered a strong correlation between the risk of osteoarthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback